This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Atropine sulfate injection (2015-06-23)
- Starting date:
- June 23, 2015
- Posting date:
- July 7, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-54110
Recalled Products
- Atropine sulfate injection 0.5 mg / 5 mL
- Atropine sulfate injection 1 mg / 5 mL
Reason
Inaccurate dosing information on inner and outer labels.
Depth of distribution
Wholesalers and Hospitals
Affected products
A. Atropine sulfate injection 0.5 mg / 5 mL
DIN, NPN, DIN-HIM
DIN 02426269
Dosage form
Solution
Strength
Atropine Sulfate 0.5 mg / 5 mL
Lot or serial number
- 6500565
Companies
- Recalling Firm
-
BioSyvent Pharma Inc.
170 Attwell Drive, Suite 520
Toronto
M9W 5Z5
Ontario
CANADA
- Marketing Authorization Holder
-
BioSyvent Pharma Inc.
170 Attwell Drive, Suite 520
Toronto
M9W 5Z5
Ontario
CANADA
B. Atropine sulfate injection 1 mg / 5 mL
DIN, NPN, DIN-HIM
DIN 02426277
Dosage form
Solution
Strength
Atropine Sulfate 1 mg / 5 mL
Lot or serial number
- 6500580
Companies
- Recalling Firm
-
BioSyvent Pharma Inc.
170 Attwell Drive, Suite 520
Toronto
M9W 5Z5
Ontario
CANADA
- Marketing Authorization Holder
-
BioSyvent Pharma Inc.
170 Attwell Drive, Suite 520
Toronto
M9W 5Z5
Ontario
CANADA